Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Importance of Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine Before Renal Transplantation

NCT03024229 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT03024229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03024229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Importance of Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine Before Renal Transplantation
Lead sponsor
University Hospital, Tours
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2017
Completion date
January 14, 2020
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplantation